xmlns:atom="http://www.w3.org/2005/Atom" xmlns:atom="http://www.w3.org/2005/Atom"

SCHEDULES

SCHEDULE 13U.K.Tax relief for expenditure on vaccine research etc

Modifications etc. (not altering text)

C1Sch. 13 modified (with effect as specified in art. 2 of the commencing S.I. of the commencing S.I.) by Finance Act 2004 (c. 12), s. 53(2)(6); S.I. 2004/3268, art. 2

Part 5U.K.Supplementary provisions

InterpretationU.K.

27(1)In this Schedule—

(2)Section 839 of the Taxes Act 1988 (connected persons) applies for the purposes of this Schedule.

(3)For the purposes of this Schedule a company not within the charge to corporation tax that incurs qualifying expenditure is treated as having such accounting periods as it would have—

(a)if it carried on a trade consisting of the qualifying R&D activity on which the expenditure is incurred, and

(b)if it had started to carry on that trade when it started to carry on that activity.

Textual Amendments

F1Words in Sch. 13 para. 27(1) repealed (with effect in accordance with s. 723(1)(a)(b) of the amending Act) by Income Tax (Earnings and Pensions) Act 2003 (c. 1), s. 723, Sch. 8 Pt. 1 (with Sch. 7)

Commencement Information

I1Sch. 13 has effect in relation to expenditure incurred on or after 22.4.2003 by The Finance Act 2002, Schedule 13 (Appointed Day) Order 2003 (S.I. 2003/1472), art. 2 (with para. 28(1))